Literature DB >> 21825245

N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.

Jonathan H Smith1, Radhika Dhamija, Brian D Moseley, Paola Sandroni, Claudia F Lucchinetti, Vanda A Lennon, Orhun H Kantarci.   

Abstract

OBJECTIVES: To report the clinical, laboratory, and radiographic features and the response to plasmapheresis in a patient with encephalopathy, opsoclonus, and myoclonus whose cerebrospinal fluid was positive for N-methyl-D-aspartate receptor-IgG.
DESIGN: Case report.
SETTING: St Marys Hospital, Rochester, Minnesota. PATIENT: A 27-year-old woman with a history of episodic migraine developed subacute progressive myoclonus, opsoclonus, and encephalopathy.
RESULTS: Magnetic resonance imaging demonstrated nodular leptomeningeal enhancement in the superior cerebellar folia and subsequent T2 hyperintensities in the periventricular regions and amygdala. A positron emission tomographic scan of the head demonstrated predominantly frontotemporoparietal cortical hypometabolism with sparing of the primary sensory and motor cortices. Cerebrospinal fluid examination revealed a lymphocytic pleocytosis, mildly elevated protein level, elevated IgG index, and positive oligoclonal banding. Autoimmune cerebrospinal fluid screening revealed a neural-specific IgG that bound to synapse-rich regions of mouse hippocampus and cerebellar granular layer; the neural-specific IgG was confirmed to be N-methyl-D-aspartate receptor specific. No neoplasm was detected by physical examination or by whole-body computed tomography and positron emission tomography. A 5-day course of high-dose intravenous methylprednisolone sodium succinate yielded limited improvement, and the patient subsequently required intensive care unit admission following a pulseless electrical activity arrest associated with pulmonary embolism. The encephalopathy improved dramatically after plasmapheresis.
CONCLUSIONS: This case highlights opsoclonus and myoclonus as manifestations of autoimmune N-methyl-D-aspartate receptor encephalitis in the setting of a novel appearance on positron emission tomography, and it shows a remarkable clinical response to plasmapheresis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825245     DOI: 10.1001/archneurol.2011.166

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

Review 1.  Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.

Authors:  Hanul Srinivas Bhandari
Journal:  BMJ Case Rep       Date:  2012-08-08

2.  Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.

Authors:  Jessica A Panzer; Ronan Anand; Josep Dalmau; David R Lynch
Journal:  J Neuroimmunol       Date:  2015-07-26       Impact factor: 3.478

Review 3.  Glutamatergic autoencephalitides: an emerging field.

Authors:  Jessica A Panzer; Amy J Gleichman; David R Lynch
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

4.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

5.  Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yingying Su
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

6.  [Therapeutic apheresis for autoimmune encephalitis: a nationwide data collection].

Authors:  S Ehrlich; C M Fassbender; C Blaes; C Finke; A Günther; L Harms; F Hoffmann; K Jahner; R Klingel; A Kraft; T Lempert; M Tesch; J Thomsen; H Topka; J Jochim; C Veauthier; W Köhler
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

7.  Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus.

Authors:  Xavier Finné Lenoir; Christian Sindic; Vincent van Pesch; Souraya El Sankari; Marianne de Tourtchaninoff; Roger Denays; Philippe Hantson
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

Review 8.  Paraneoplastic neurological syndromes.

Authors:  F Leypoldt; K-P Wandinger
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 9.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

Review 10.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.